Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements

SIMPLE SUMMARY: The growing efficacy and availability of new targeted systemic therapies have markedly improved the prognosis of metastatic lung cancer patients harboring ALK rearrangements. The use of effective targeted therapies capable of maintaining a prolonged control of disease, for as long as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisano, Chiara, De Filippis, Marco, Jacobs, Francesca, Novello, Silvia, Reale, Maria Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833409/
https://www.ncbi.nlm.nih.gov/pubmed/35158987
http://dx.doi.org/10.3390/cancers14030718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833409/
https://www.ncbi.nlm.nih.gov/pubmed/35158987
http://dx.doi.org/10.3390/cancers14030718

Ejemplares similares